A live audio webcast of the Piper Sandler Healthcare Conference fireside chat can be accessed here and on the LENZ ...

It is driven by the rising prevalence of these vision conditions. The global myopia and presbyopia treatment market is set to ...

Comfort was the name of the game when OT spoke with contact lens manufacturers and suppliers about recent trends and launches ...

BEIJING - Major international eye care and eyewear provider, EssilorLuxottica, has a clear vision for long-term development ...

Major international eye care and eyewear provider EssilorLuxottica has a clear vision for long-term development in China as the country growing purs ...

In October, Ocuphire Pharma acquired Opus Genetics, creating a leading, clinical-stage company focused on the development of gene therapy ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

You may have seen advertisements claiming to eliminate the need for eyeglasses through vision therapy or vision training – ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients ...

As CIIE provides us with a unique platform to engage with governments, academic institutions, industrial partners, and media, ...

Amalgamated Bank reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 3.2% in the 3rd quarter, ...

Furthermore, th... Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising Prevalence Drives Demand with AI Redefining Market Landscape - Technavio PR Newswire NEW ...